carbamazepine has been researched along with Headache Disorders in 4 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Headache Disorders: Various conditions with the symptom of HEADACHE. Headache disorders are classified into major groups, such as PRIMARY HEADACHE DISORDERS (based on characteristics of their headache symptoms) and SECONDARY HEADACHE DISORDERS (based on their etiologies). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The most effective long-term treatments for tension-type mid-facial pain and facial migraine were low-dose amitriptyline and low-dose amitriptyline and triptans, respectively." | 3.80 | Prospective three-year follow up of a cohort study of 240 patients with chronic facial pain. ( Agius, AM; Jones, NS; Muscat, R, 2014) |
| " The goal of this study is to describe three patients diagnosed with migraine and epilepsy (both under control) who evolved into status migrainosus after the introduction of oxcarbazepine (OXC), as part of a switch off from carbamazepine (CBZ)." | 3.74 | Uncontrolled headache induced by oxcarbazepine. ( Amaral, VC; Crippa, A; de Paola, L; Della Colleta, MV; Di Stani, F; Piovesan, EJ; Silvado, CE; Teive, HG; Werneck, LC, 2007) |
| "Suspected central nervous system infection was investigated and treated with cefotaxime." | 1.40 | A hunt for the source of sepsis. ( Adebajo, A; Grandidge, L; Sharlala, H; Thistleton, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Man, YH | 1 |
| Qi, JJ | 1 |
| Yu, TM | 1 |
| Yao, G | 1 |
| Agius, AM | 1 |
| Jones, NS | 1 |
| Muscat, R | 1 |
| Thistleton, S | 1 |
| Grandidge, L | 1 |
| Sharlala, H | 1 |
| Adebajo, A | 1 |
| Piovesan, EJ | 1 |
| Teive, HG | 1 |
| de Paola, L | 1 |
| Silvado, CE | 1 |
| Crippa, A | 1 |
| Amaral, VC | 1 |
| Della Colleta, MV | 1 |
| Di Stani, F | 1 |
| Werneck, LC | 1 |
4 other studies available for carbamazepine and Headache Disorders
| Article | Year |
|---|---|
Epicrania Fugax with a Novel Sign: Pain Paroxysms with Parallel Forward or Backward Trajectories.
Topics: Adult; Analgesics, Non-Narcotic; Carbamazepine; Female; Headache Disorders; Humans; Male; Middle Age | 2020 |
Prospective three-year follow up of a cohort study of 240 patients with chronic facial pain.
Topics: Adolescent; Adult; Amitriptyline; Analgesics, Non-Narcotic; Carbamazepine; Chronic Pain; Facial Pain | 2014 |
A hunt for the source of sepsis.
Topics: Adult; Analgesics, Non-Narcotic; Carbamazepine; Central Nervous System Infections; Diagnosis, Differ | 2014 |
Uncontrolled headache induced by oxcarbazepine.
Topics: Acute Disease; Adult; Anticonvulsants; Brain Neoplasms; Carbamazepine; Central Nervous System Vascul | 2007 |